MLNR
MOLECULAR TARGETmotilin receptor
MLNR (motilin receptor) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MLNR
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Motilin | 1.95 | 6 |
| 2 | Azithromycin | 0.69 | 1 |
| 3 | Duloxetine Hydrochloride | 0.69 | 1 |
| 4 | Aripiprazole | 0.69 | 1 |
| 5 | Astemizole Antihistamine drug now withdrawn from | 0.69 | 1 |
| 6 | Benzethonium Bactericidal cationic quaternary ammonium surfactant used as | 0.69 | 1 |
| 7 | Carvedilol | 0.69 | 1 |
| 8 | Chlorhexidine | 0.69 | 1 |
| 9 | Fluspirilene | 0.69 | 1 |
| 10 | Sorafenib | 0.69 | 1 |
About MLNR as a Drug Target
MLNR (motilin receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented MLNR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MLNR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.